2024 annual financial data
Castle Biosciences 2024 Operating margin
Castle Biosciences 2024 operating margin with verified reported values.
Direct answer
Operating margin was 2.61%.
Operating income was 8,670,000 USD and net income was 18,245,000 USD.
Operating cash flow was 64,866,000 USD.
Get free Castle Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 332,069,000 USD
- Operating income
- 8,670,000 USD
- Net income
- 18,245,000 USD
- Operating cash flow
- 64,866,000 USD